Apixaban vs Conventional Therapy for Acute VTE: AMPLIFY Trial Insights

(3:33)

Heart Minute | AMPLIFY Trial

(1:27)

AMPLIFY Trial: Acalabrutinib Plus Venetoclax for CLL

(10:22)

CLL highlights from ASH: the Phase III AMPLIFY trial

(47)

Interim results of AMPLIFY: AV/AVO versus chemoimmunotherapy for first-line treatment of CLL

(2:48)

Heart Minute | AMPLIFY Trial

(1:27)

Long-term Apixaban for VTE: Insights from the AMPLIFY-EXT Trial

(3:27)

ASH24: Interim Analysis of the Multicenter, Open-Label, Randomized, Phase 3 AMPLIFY

(6:23)

The MagnetisMM-20 trial of elranatamab with carfilzomib and dexamethasone in RRMM

(1:54)

Heart Minute | AMPLIFY Trial

(1:27)

How to activate and use your Glofox Amplify free trial 👐

(3:53)

AMPLIFY-201: ELI-002 2P Vaccine for Pancreatic and Colorectal Cancer

(7:19)

Cardiology Countdown | PAD Walking, STOP-HF and AMPLIFY

(5:4)

Confundus Charm Card Trial - First Encounter - Confuse and Amplify|Harry Potter Magic Awakened #54.7

(25)

Amplify the Site Voice in Clinical Trial Finances

(4:2)

Axway AMPLIFY For Medication Adherence

(8:21)

Your Glofox Amplify Free Trial - Activation Walkthrough🚶

(2:15)

ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL

(22:)

AMPLIFY Platform Demo | Introduction to the AMPLIFY Platform

(6:8)